Efficacy of sublingual apomorphine in Parkinson's disease.
作者信息
Durif F, Deffond D, Tournilhac M
出版信息
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1105. doi: 10.1136/jnnp.53.12.1105.
Abstract
摘要
相似文献
1
Efficacy of sublingual apomorphine in Parkinson's disease.舌下含服阿扑吗啡治疗帕金森病的疗效
J Neurol Neurosurg Psychiatry. 1990 Dec;53(12):1105. doi: 10.1136/jnnp.53.12.1105.
2
Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.阿扑吗啡治疗帕金森病：皮下注射与舌下含服途径的比较。
J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):101-3. doi: 10.1136/jnnp.56.1.101.
3
Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease.帕金森病患者单次舌下含服阿扑吗啡后血浆浓度与临床疗效的关系。
Eur J Clin Pharmacol. 1991;41(5):493-4. doi: 10.1007/BF00626377.
4
Sublingual apomorphine (Kynmobi) for Parkinson's disease.用于帕金森病的舌下含服阿扑吗啡（Kynmobi）。
Med Lett Drugs Ther. 2020 Oct 19;62(1609):165-166.
5
Apomorphine for motor fluctuations and freezing in Parkinson's disease.阿扑吗啡用于帕金森病的运动波动和冻结现象
Ann Pharmacother. 1995 Mar;29(3):282-8. doi: 10.1177/106002809502900310.
6
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease.阿扑吗啡的一种新型舌下制剂用于帕金森病患者的治疗。
Mov Disord. 1996 Nov;11(6):633-8. doi: 10.1002/mds.870110607.
7
Subcutaneous apomorphine in Parkinson's disease.帕金森病中的皮下注射阿扑吗啡
Lancet. 1988 Apr 23;1(8591):943. doi: 10.1016/s0140-6736(88)91755-2.
8
Sublingual apomorphine solution in Parkinson's disease.帕金森病中的舌下阿扑吗啡溶液
Med J Aust. 1991 Sep 16;155(6):371-4. doi: 10.5694/j.1326-5377.1991.tb101311.x.
9
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述
Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.
10
Sublingual apomorphine and Parkinson's disease.舌下含服阿扑吗啡与帕金森病
J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1440. doi: 10.1136/jnnp.52.12.1440.
引用本文的文献
1
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience.间歇性使用阿扑吗啡用于帕金森病“关”期急救：对三十多年临床经验的实用综述
Mov Disord Clin Pract. 2022 Oct 27;10(2):190-208. doi: 10.1002/mdc3.13593. eCollection 2023 Feb.
2
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.皮下注射阿扑吗啡治疗晚期帕金森病：长期随访
J Neurol Neurosurg Psychiatry. 1998 Nov;65(5):709-16. doi: 10.1136/jnnp.65.5.709.
3
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.笔式注射阿扑吗啡治疗晚期帕金森病的“剂末现象”：一项双盲、安慰剂对照研究
J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):681-7. doi: 10.1136/jnnp.58.6.681.
4
Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease.帕金森病患者单次舌下含服阿扑吗啡后血浆浓度与临床疗效的关系。
Eur J Clin Pharmacol. 1991;41(5):493-4. doi: 10.1007/BF00626377.
本文引用的文献
1
Similarities between neurologic effects of L-dopa and of apomorphine.左旋多巴与阿扑吗啡对神经系统作用的相似性。
N Engl J Med. 1970 Jan 1;282(1):31-3. doi: 10.1056/NEJM197001012820107.
2
Subcutaneous apomorphine in Parkinson's disease.帕金森病中的皮下注射阿扑吗啡
Lancet. 1988 Apr 23;1(8591):943. doi: 10.1016/s0140-6736(88)91755-2.
3
Subcutaneous apomorphine in parkinsonian on-off oscillations.皮下注射阿扑吗啡治疗帕金森病的开关现象
Lancet. 1988 Feb 20;1(8582):403-6. doi: 10.1016/s0140-6736(88)91193-2.
4
[Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].[皮下注射阿扑吗啡治疗帕金森病运动波动]
Rev Neurol (Paris). 1990;146(2):116-22.
5
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.左旋多巴诱发异动症的起始与剂末现象。增加左旋多巴每日剂量的可能治疗方法。
Arch Neurol. 1978 May;35(5):261-3. doi: 10.1001/archneur.1978.00500290007002.
Zotero 插件